Stemedica Cell Technologies, Inc.
5 clinical trials · Sponsor
◉ Watch Stemedica Cell Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 (NCT04780685) | Stemedica Cell Technologies, Inc. | 2021-03-20 |
Track Stemedica Cell Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.